1. Home
  2. OWLT vs OTLK Comparison

OWLT vs OTLK Comparison

Compare OWLT & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OWLT
  • OTLK
  • Stock Information
  • Founded
  • OWLT 2013
  • OTLK 2010
  • Country
  • OWLT United States
  • OTLK United States
  • Employees
  • OWLT N/A
  • OTLK N/A
  • Industry
  • OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OWLT Health Care
  • OTLK Health Care
  • Exchange
  • OWLT Nasdaq
  • OTLK Nasdaq
  • Market Cap
  • OWLT 73.9M
  • OTLK 64.6M
  • IPO Year
  • OWLT N/A
  • OTLK 2016
  • Fundamental
  • Price
  • OWLT $4.69
  • OTLK $1.83
  • Analyst Decision
  • OWLT
  • OTLK Strong Buy
  • Analyst Count
  • OWLT 0
  • OTLK 5
  • Target Price
  • OWLT N/A
  • OTLK $21.00
  • AVG Volume (30 Days)
  • OWLT 31.1K
  • OTLK 892.5K
  • Earning Date
  • OWLT 03-06-2025
  • OTLK 02-12-2025
  • Dividend Yield
  • OWLT N/A
  • OTLK N/A
  • EPS Growth
  • OWLT N/A
  • OTLK N/A
  • EPS
  • OWLT N/A
  • OTLK N/A
  • Revenue
  • OWLT $78,575,000.00
  • OTLK N/A
  • Revenue This Year
  • OWLT $40.64
  • OTLK N/A
  • Revenue Next Year
  • OWLT $20.09
  • OTLK $396.84
  • P/E Ratio
  • OWLT N/A
  • OTLK N/A
  • Revenue Growth
  • OWLT 74.76
  • OTLK N/A
  • 52 Week Low
  • OWLT $3.20
  • OTLK $0.87
  • 52 Week High
  • OWLT $6.25
  • OTLK $12.85
  • Technical
  • Relative Strength Index (RSI)
  • OWLT 55.83
  • OTLK 39.18
  • Support Level
  • OWLT $4.36
  • OTLK $1.79
  • Resistance Level
  • OWLT $4.65
  • OTLK $2.26
  • Average True Range (ATR)
  • OWLT 0.17
  • OTLK 0.18
  • MACD
  • OWLT 0.03
  • OTLK 0.00
  • Stochastic Oscillator
  • OWLT 89.80
  • OTLK 6.09

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Share on Social Networks: